Sage Journals: Discover world-class research

Open access

Research article

First published 2023-05

Complement system in Anti-CD20 mAb therapy for cancer: A mini-review

Yiwen Gao

International Journal of Immunopathology and Pharmacology

Open access

Review article

First published 2026

A new glycoengineered form of anti-CD20 monoclonal antibody in treatment of multiple sclerosis

Krzysztof Selmaj, Ralf Gold, Igor Selmaj [...]

Therapeutic Advances in Neurological Disorders

Retricted access

Case report

First published 2023-9

Regression of bilateral orbital inflammation with anti-CD20 in a patient with relapsing granulomatosis with polyangiitis: A case report

Niccolò Castellino, Salvatore Scuto, Luca Zanoli [...]

European Journal of Ophthalmology

Free access

Research article

First published 2006-10

Chronic Refractory Idiopathic Thrombocytopenic Purpura (ITP) and Anti-CD20 Monoclonal Antibody: A Case Report

S. Z. Latifzadeh, V. Entezari

Clinical and Applied Thrombosis/Hemostasis

Open access

Research article

First published 2022-6

Preserved T cell responses to SARS-CoV-2 in anti-CD20 treated multiple sclerosis

Tatjana Schwarz, Carolin Otto, Terry C Jones [...]

Multiple Sclerosis Journal

Open access

Research article

First published 2026-1

Safety and efficacy of extended versus standard interval dosing of anti-CD20 therapy in multiple sclerosis – A meta-analysis

Mahmoud Elkhooly, Rhea Jacob, Torge Rempe

Multiple Sclerosis Journal – Experimental,Translational and Clinical

Retricted access

Research article

First published 2021-12

Anti-CD20 therapy corrects a CD8 regulatory T cell deficit in multiple sclerosis

Quentin Howlett-Prieto, Xuan Feng, John F Kramer [...]

Multiple Sclerosis Journal

Open access

Review article

First published 2026

Economic value of anti-CD20 therapies in multiple sclerosis: a systematic review of cost-effectiveness studies

Johannes Heinemann, Marco Zirkel, Oliver Schoeffski [...]

Therapeutic Advances in Neurological Disorders

Open access

Research article

First published 2025-1

No evidence of fluctuations in daily step count between infusions in people with multiple sclerosis treated with anti-CD20 monoclonal antibodies

Valerie J Block, Kyra Henderson, Shane Poole [...]

Multiple Sclerosis Journal – Experimental,Translational and Clinical

Retricted access

Research article

First published 2012-12

Generation of a Potent Recombinant Homophilic Chimeric Anti-CD20 Antibody

Heinz Kohler, Kyle Rector, Jean Amick

Monoclonal Antibodies in Immunodiagnosis & Immunotherapy

Search results